Qiagen Plans Greater Push into Molecular Dx, Bolsters Sales Force to Peddle New Products

Nov 10, 2005

Qiagen has launched a new avian flu molecular diagnostic test and intends to launch another 12 assays for bacterial and viral infections within the next four months as it continues to focus its business on the diagnostics market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

An Expensive Deal

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Figuring Out Who It'll Work For

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

This Week in Nature

In Nature this week: paternal age associated with de novo mutations in children, and more.

Ye Old P-Value

Nature News writes that researchers are still wrangling over the role of the p-value.

Main menu